mar 18, 2000 - Whelan
Description:
Can PMRT improve survival even further if the risk of dying from micrometastatic disease is minimized through the use of systemic therapy?
* reduced LRF by 75%
* improved OS by 17%
Metaanalysis of 18 PMRT trials
Added to timeline:
PMRT
Date:
